Eli Lilly revenue outlook shows clear growth potential
Eli Lilly revenue outlook is boosted by weight-loss shots, offsetting sales misses. Explore the implications for investors and market trends.
Ultimate Blogging Championship
Cryptocurrency Investment and Trading
Eli Lilly revenue outlook is boosted by weight-loss shots, offsetting sales misses. Explore the implications for investors and market trends.
Venezuelan crude impact could mean Rs 12,600 crore added to RIL’s EBITDA. Here’s what investors need to know.
Vedanta shares fall ahead of board meeting to discuss FY27 interim dividend. Investors are watching closely as the record date is set.
Raymond shares slump highlights key market trends and support levels to watch.